Medexus Pharmaceuticals Toekomstige groei
Future criteriumcontroles 5/6
Medexus Pharmaceuticals is forecast to grow earnings and revenue by 50.3% and 9.3% per annum respectively. EPS is expected to grow by 45.7% per annum. Return on equity is forecast to be 29% in 3 years.
Belangrijke informatie
50.3%
Groei van de winst
45.7%
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 54.4% |
| Inkomstengroei | 9.3% |
| Toekomstig rendement op eigen vermogen | 29.0% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 18 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings
Aug 19
Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 10Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth
Jul 31The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet
Jun 15Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden
Apr 25Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive
Mar 03Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story
Jan 06Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors
Oct 11Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 11Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky
Jan 19Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Sep 22Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?
Dec 16Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially
Aug 21Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?
Aug 04Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 3/31/2027 | 116 | 16 | N/A | 28 | 3 |
| 3/31/2026 | 99 | 1 | N/A | 19 | 4 |
| 3/31/2025 | 103 | 3 | N/A | 16 | 6 |
| 6/30/2024 | 109 | 1 | 22 | 23 | N/A |
| 3/31/2024 | 113 | 0 | 18 | 19 | N/A |
| 12/31/2023 | 116 | 6 | 21 | 21 | N/A |
| 9/30/2023 | 119 | 5 | 13 | 13 | N/A |
| 6/30/2023 | 117 | 3 | 6 | 7 | N/A |
| 3/31/2023 | 108 | 1 | -2 | -1 | N/A |
| 12/31/2022 | 100 | -11 | -3 | -2 | N/A |
| 9/30/2022 | 92 | -11 | -3 | -1 | N/A |
| 6/30/2022 | 82 | 2 | 0 | 2 | N/A |
| 3/31/2022 | 77 | -3 | -9 | -1 | N/A |
| 12/31/2021 | 74 | -8 | -17 | -1 | N/A |
| 9/30/2021 | 77 | -20 | -18 | -1 | N/A |
| 6/30/2021 | 77 | -31 | -21 | -5 | N/A |
| 3/31/2021 | 80 | -28 | -6 | 5 | N/A |
| 12/31/2020 | 79 | -19 | -1 | 0 | N/A |
| 9/30/2020 | 69 | -9 | 1 | 1 | N/A |
| 6/30/2020 | 64 | -7 | 1 | 1 | N/A |
| 3/31/2020 | 56 | -5 | -3 | -2 | N/A |
| 12/31/2019 | 47 | -4 | -1 | 0 | N/A |
| 9/30/2019 | 45 | -3 | -1 | 0 | N/A |
| 6/30/2019 | 36 | -6 | -2 | -1 | N/A |
| 3/31/2019 | 25 | -5 | -1 | -1 | N/A |
| 12/31/2018 | 17 | -5 | -3 | -2 | N/A |
| 9/30/2018 | 9 | -5 | -1 | -1 | N/A |
| 6/30/2018 | 8 | -2 | -2 | -2 | N/A |
| 3/31/2018 | 8 | -3 | N/A | -3 | N/A |
| 12/31/2017 | 8 | -3 | N/A | -3 | N/A |
| 9/30/2017 | 7 | -3 | N/A | -4 | N/A |
| 6/30/2017 | 6 | -3 | N/A | -4 | N/A |
| 3/31/2017 | 5 | -1 | N/A | -1 | N/A |
| 12/31/2016 | 4 | 1 | N/A | 1 | N/A |
| 9/30/2016 | 3 | 1 | N/A | 1 | N/A |
| 6/30/2016 | 3 | 1 | N/A | 1 | N/A |
| 3/31/2016 | 3 | -2 | N/A | -1 | N/A |
| 12/31/2015 | 3 | -4 | N/A | -3 | N/A |
| 9/30/2015 | 2 | -4 | N/A | -3 | N/A |
| 6/30/2015 | 2 | -5 | N/A | -3 | N/A |
| 3/31/2015 | 2 | -4 | N/A | -4 | N/A |
| 12/31/2014 | 3 | -4 | N/A | -3 | N/A |
| 9/30/2014 | 3 | -4 | N/A | -3 | N/A |
| 6/30/2014 | 4 | -3 | N/A | -3 | N/A |
| 3/31/2014 | 3 | -3 | N/A | -1 | N/A |
| 12/31/2013 | 4 | -2 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: MDP's forecast earnings growth (50.3% per year) is above the savings rate (2.2%).
Winst versus markt: MDP's earnings (50.3% per year) are forecast to grow faster than the Canadian market (16.2% per year).
Hoge groeiwinsten: MDP's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: MDP's revenue (9.3% per year) is forecast to grow faster than the Canadian market (6.9% per year).
Hoge groei-inkomsten: MDP's revenue (9.3% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: MDP's Return on Equity is forecast to be high in 3 years time (29%)